A new aligned pathway has been established by the UK Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) to facilitate earlier patient access to medicines, according to recently published guidance.
The Lancet Oncology published a clinical update in Oncology on 10 Apr 2026. The item focuses on UK MHRA–NICE pathway to create faster regulatory approval. Open the detail page to review the full original feed content.